Skip to content

A study 2 for evaluation of inter-fractional changes in internal organs and its dose distributions for carbon ion radiotherapy

A study 2 for evaluation of inter-fractional changes in internal organs and its dose distributions for carbon ion radiotherapy - Evaluation 2 of influence for inter-fractional changes for carbon ion radiotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029495
Enrollment
30
Registered
2017-10-16
Start date
2017-10-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate, pancreatic, or uterine cancer

Interventions

Twelve to sixteen times at maximum (three to four times at least) of CT acquisitions and one time of 4 dimensional CT acquisition

Sponsors

Gunma University Heavy Ion Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patient has a prostate, pancreatic, or uterine cancer, and he/she will receive carbon ion radiotherapy. The treatment fractions is twelve to sixteen. ECOG Perfomance Status (PS)=0-2. Over 20 years. It is possible to get his/her agreement of this study by text.

Exclusion criteria

Exclusion criteria: Not emergency irradiation case. Inappropriate case determined by doctor.

Design outcomes

Primary

MeasureTime frame
To evaluate tumor movement using CT images acquired on the treatment days and the treatment planning CT images. To recalculate the CTV coverage (V95%) on the current CT images and compare with the CTV coverage on the treatment planning.

Countries

Japan

Contacts

Public ContactTatsuya Ohno

Gunma University Heavy Ion Medical Center

tohno@gunma-u.ac.jp027-220-8378

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026